Sponsors (4)
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Introduced March 5, 2026 by Rashida Tlaib · Last progress March 5, 2026
Creates a new federal research entity by adding a National Institute for Biomedical Research and Development to the Public Health Service Act and makes several conforming changes in related public health and criminal statutes. The bill inserts unspecified statutory text to establish the institute and alters parts of 42 U.S.C. and 18 U.S.C.; exact program authorities, funding, and operational details are not included in the provided text.
The bill creates a federal institute to boost biomedical R&D and strengthen public‑health preparedness—potentially improving treatments and coordination—but increases federal spending and introduces legal, privacy, and compliance risks that may burden researchers and health institutions.
Patients (including those with chronic conditions), hospitals/health systems, and the public will benefit from a new National Institute for Biomedical Research and Development that strengthens public‑health preparedness and accelerates development of treatments and medical countermeasures for emerging health threats.
Scientists and biomedical researchers gain a federal institute that could provide increased funding opportunities, coordinated research programs, and clearer R&D priorities to support biomedical innovation.
Scientists, researchers, and hospitals may face legal uncertainty and potential expansion of penalties or reporting requirements due to added or undefined language in 18 U.S.C. §216 and related provisions, which could chill research or complicate institutional compliance.
Researchers and research institutions could face new oversight, data‑sharing, or compliance obligations tied to the institute that raise privacy risks, administrative burdens, and costs, potentially discouraging collaboration or slowing projects.
Taxpayers will bear increased federal spending to establish and run the new institute, adding to federal outlays.